Literature DB >> 15771606

Genetic examination of children suffering from cystic fibrosis.

Ediba Saracević1, Amira Redzić.   

Abstract

CFTR protein (cystic fibrosis trans membrane conductance regulator) is expressed in multiple epithelial tissues, including upper and lower respiratory tracts, pancreas, sweat glands and gastrointestinal tract. More than 800 mutations and 100 polymorphic variants of DNA sequences were identified in patients with CF (Cystic fibrosis) and CFTR-diseases. In this study, genetic CFTR analysis of the children suffering from chronic lung disease (cystic fibrosis) is presented. They are treated and regularly controlled at the Pediatric hospital Sarajevo. CFTR analysis was done in 9 cases, 4 boys (44.4%) and 5 girls (55.55%). There are 3 children (33.3%) in the age group 1 to 3 years, 1 child (11.1%) in the age group 3 to 6 years, 3 children (33.3%) in the age group 6 to 9 years and 2 children (22.2%) in the age group 9 to 12 years. Genetic analysis was conducted at the Medical center for molecular biology, School of Medicine, Ljubljana. PCR method with PAGE and direct sequestration on ABI PRISM 31 was applied. The majority of children (7 children, i.e. 77.77%) had CFTR mutation Delta F 508 whilst one child had G542X mutation and one child R 1174 mutation. The purpose of this study is to emphasize the need for CFTR gene identification in the institutes of our country.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15771606      PMCID: PMC7214057          DOI: 10.17305/bjbms.2005.3339

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  5 in total

1.  Cystic fibrosis: a 2002 update.

Authors:  David M Orenstein; Glenna B Winnie; Harold Altman
Journal:  J Pediatr       Date:  2002-02       Impact factor: 4.406

Review 2.  Cystic fibrosis: a worldwide analysis of CFTR mutations--correlation with incidence data and application to screening.

Authors:  Joseph L Bobadilla; Milan Macek; Jason P Fine; Philip M Farrell
Journal:  Hum Mutat       Date:  2002-06       Impact factor: 4.878

3.  Regional mucociliary clearance in patients with cystic fibrosis.

Authors:  M Robinson; S Eberl; C Tomlinson; E Daviskas; J A Regnis; D L Bailey; P J Torzillo; M Menache; P T Bye
Journal:  J Aerosol Med       Date:  2000

Review 4.  Interstitial lung disease in a baby with a de novo mutation in the SFTPC gene.

Authors:  F Brasch; M Griese; M Tredano; G Johnen; M Ochs; C Rieger; S Mulugeta; K M Müller; M Bahuau; M F Beers
Journal:  Eur Respir J       Date:  2004-07       Impact factor: 16.671

5.  Normal nasal mucociliary clearance in CF children: evidence against a CFTR-related defect.

Authors:  D McShane; J C Davies; T Wodehouse; A Bush; D Geddes; E W F W Alton
Journal:  Eur Respir J       Date:  2004-07       Impact factor: 16.671

  5 in total
  1 in total

1.  Profile of cystic fibrosis in a single referral center in Egypt.

Authors:  Mona M El-Falaki; Walaa A Shahin; Noussa R El-Basha; Aliaa A Ali; Dina A Mehaney; Mona M El-Attar
Journal:  J Adv Res       Date:  2013-07-15       Impact factor: 10.479

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.